ImmuCell Corporation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
ImmuCell Corporation (ICCC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $30.12 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2021-03-30
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2020 was $30.12K, a 20.34% decline from fiscal 2019.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2019 was $37.81K.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2017 was $55.95K, a 318.76% increase from fiscal 2016.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2016 was $13.36K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2020-12-31 | $30.12K 10-K · filed 2021-03-30 |
| 2019-12-31 | $37.81K 10-K · filed 2021-03-30 |
| 2017-12-31 | $55.95K 10-K · filed 2018-03-29 |
| 2016-12-31 | $13.36K 10-K · filed 2018-03-29 |
| 2015-12-31 | -$7.52K 10-K · filed 2017-03-30 |
| 2014-12-31 | $10.20K 10-K · filed 2016-03-25 |
| 2013-12-31 | $10.53K 10-K · filed 2016-03-25 |
| 2012-12-31 | $9.77K 10-K · filed 2015-03-26 |
| 2011-12-31 | $8.04K 10-K · filed 2014-03-26 |
| 2010-12-31 | $10.03K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |